SCHEMBL19085617

SCHEMBL19085617

Clc1cc(Cl)nc(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190461 0.78
SCHEMBL14134960 0.78
SCHEMBL12072827 0.74
SCHEMBL280557 0.74
SCHEMBL10234942 0.72
Formaldehyde SCHEMBL28876984 0.71 S1PR2 (0.42)
SCHEMBL23181498 0.69 GABRB3 (0.36)
SCHEMBL19301335 0.69 MAPT (0.34)
SCHEMBL18068188 0.69 SMN1; SMN2 (0.37)
SCHEMBL13045682 0.69 GRM5 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689388-B1 Indole AHR inhibitors and uses thereof Ikena Oncology, Inc. (US) 2020-06-23 US disclosed
WO-2017117239-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS FLATLEY DISCOVERY LAB, LLC (US) 2017-07-06 WO disclosed